Details - Information last confirmed on September 3, 2020

WIPH1A - Generic Injectable Pharmaceuticals Development Company in Wisconsin

Our firm is pleased to present an opportunity to acquire a pharmaceuticals development company in Wisconsin. The company specializes in generic injectables, analytical development, and formulations development.

They carry FDA registration and DEA registration for narcotics class 1-4. They own and operate out of a 35,000 square ft facility located on 3 acres of land with full cGMP analytics lab. Their team of 12 is willing to stay on making this fully turn key for a new owner.

The company generated $3 million revenue over the last two years and has operated at cash flow break even. The sole owner has invested more than $13 million into the facility, land, and equipment. He is retiring and selling due to health issues.

The price for this opportunity is $13 million.

Learn More

Sign up for a free membership. Get instant access to thousands of listings. Learn about our membership plans.

Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum.